)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Ajanta Pharma (AJANTPHARM) investor relations material
Ajanta Pharma Q1 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 25/26 earnings summary28 Jul, 2025
Executive summary
Q1 FY26 revenue from operations grew 14% year-over-year to ₹1,303 crore, with resilient margins and strong performance across branded generics, US generics, and emerging markets.
Branded generics contributed 73% of total revenue, with leadership in chronic therapies and first-to-market products.
EBITDA increased 6% to ₹351 crore, with a margin of 27%; adjusted for forex loss, EBITDA margin was 29%.
PAT rose 4% to ₹255 crore, with a PAT margin of 20%; excluding forex loss, PAT grew 12% year-over-year.
Focus remains on sustainable growth, long-term value creation, and outperforming IPM growth rates.
Financial highlights
Total Q1 revenue was ₹1,303 crore, up 14% from ₹1,145 crore year-over-year.
Gross margin improved to 79%, up 200 bps from last year, aided by better product mix and API prices.
EBITDA margin at 27% (₹351 crore), down from 29% last year; excluding forex loss, EBITDA margin was 29%.
PAT margin at 20% (₹255 crore), up 4% year-over-year; excluding forex loss, PAT margin was 21% with 12% growth.
Free cash flow of ₹209 crore with 82% cash conversion; cash flow from operations at ₹282 crore.
Outlook and guidance
Full-year gross margin expected at 78% ±1%.
R&D spend to move to 5% of revenue for FY26; Q1 R&D expense at 4% of revenue.
EBITDA margin guidance at 27% ±1% for FY26.
India business expected to grow at least 25% higher than IPM growth rate, targeting 10%+ if IPM grows at 8%.
Strategic focus on new product launches, expanding into new countries and therapies, and enhancing field force productivity.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Ajanta Pharma earnings date
Q2 25/263 Nov, 2025
Next Ajanta Pharma earnings date
Q2 25/263 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
Ajanta Pharma Limited is a pharmaceutical company engaged in the development, manufacturing, and marketing of generic and branded pharmaceutical formulations. The company focuses on therapeutic segments such as ophthalmology, dermatology, cardiology, and pain management. Ajanta Pharma serves domestic and international markets, supplying products across regulated and emerging markets. The company is headquartered in Mumbai, India, and its shares are listed on the BSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage